Wearifi

News

LEO Pharma is developing a wearable device based on miniature sensors and plans to assess its clinical potential in dermatology drug development.

News

Armed with new phase 3 data, Bayer is preparing to file a PET imaging agent that could accelerate the diagnosis of cardiac amyloidosis.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.